Press

Together We’re Fueling the Midwest Tech Boom

Rev1 in the News

Rev1 Ventures CEO and president plan to step down
Rev1 News
Rev1 Ventures CEO and president plan to step down
Rev1 Ventures kicks off leadership transition, launches national search for next CEO
Rev1 News
Rev1 Ventures kicks off leadership transition, launches national search for next CEO
Rev1 Ventures Launches National Search for Next CEO to Lead Next Decade of Growth
Rev1 News
Rev1 Ventures Launches National Search for Next CEO to Lead Next Decade of Growth
Inside Rev1 at the Peninsula, Columbus’s new home for tech founders
Rev1 News
Inside Rev1 at the Peninsula, Columbus’s new home for tech founders
Franklinton Peninsula development office space filled by tech startup hub
Rev1 News
Franklinton Peninsula development office space filled by tech startup hub
Load More

Buzz About Our Companies

Niobium Expands Leadership Team with Key Hires in Product and Finance as It Builds Toward an Encrypted Cloud Platform
Company News
Niobium Expands Leadership Team with Key Hires in Product and Finance as It Builds Toward an Encrypted Cloud Platform
HealthPlan Data Solutions Rebrands as Rivera, Unveiling a Bold New Era of PBM Oversight
Company News
HealthPlan Data Solutions Rebrands as Rivera, Unveiling a Bold New Era of PBM Oversight
Basking Biosciences Doses First Patients in Part B of Phase 2 Stroke Trial, Unlocks $27.5 Million Financing Tranche, and Appoints Julia C. Owens, Ph.D. as Chief Executive Officer
Company News, Funding News
Basking Biosciences Doses First Patients in Part B of Phase 2 Stroke Trial, Unlocks $27.5 Million Financing Tranche, and Appoints Julia C. Owens, Ph.D. as Chief Executive Officer
71/70 Angels, Interview With Managing Director Melinda Gloriosa
Company News
71/70 Angels, Interview With Managing Director Melinda Gloriosa
Neucore Bio Awarded Competitive Grant from the U.S. National Science Foundation for Research on Scalability of Exosome-based Therapeutics for Genetic Disease
Company News, Funding News
Neucore Bio Awarded Competitive Grant from the U.S. National Science Foundation for Research on Scalability of Exosome-based Therapeutics for Genetic Disease
Load More

Accolades

Pitchbook
Pitchbook: #1 Most Active VC in Ohio

2014 – 2018

cbinsights
CB Insights: #1 Most Active VC in Ohio

2014 – 2018

Pitchbook
Pitchbook: #2 Most Active VC in the Great Lakes

2017 – 2018

Pitchbook
Pitchbook: #9 Most Active Angel & Seed Investor in United States

2018

SSTI
SSTi: Excellence in Technology Based Economic Development Award

2012 – Increasing Access to Capital

Pitchbook
Pitchbook: #1 Most Active VC in Ohio

2014 – 2018

cbinsights
CB Insights: #1 Most Active VC in Ohio

2014 – 2018

Pitchbook
Pitchbook: #2 Most Active VC in the Great Lakes

2017 – 2018

Pitchbook
Pitchbook: #9 Most Active Angel & Seed Investor in United States

2018

SSTI
SSTi: Excellence in Technology Based Economic Development Award

2012 – Increasing Access to Capital

Press Inquiries?

For media inquiries or introductions to any of our portfolio clients, contact Ashley Baig, Director of Marketing and Communications.

Email Ashley